These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 30073897)

  • 1. Dual role of macrophage in tumor immunity.
    Tamura R; Tanaka T; Yamamoto Y; Akasaki Y; Sasaki H
    Immunotherapy; 2018 Aug; 10(10):899-909. PubMed ID: 30073897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diverse macrophages polarization in tumor microenvironment.
    Rhee I
    Arch Pharm Res; 2016 Nov; 39(11):1588-1596. PubMed ID: 27562774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of Macrophage Plasticity in the Tumor Environment: Manipulating Activation State to Improve Outcomes.
    Ricketts TD; Prieto-Dominguez N; Gowda PS; Ubil E
    Front Immunol; 2021; 12():642285. PubMed ID: 34025653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor associated macrophages provide the survival resistance of tumor cells to hypoxic microenvironmental condition through IL-6 receptor-mediated signals.
    Jeong SK; Kim JS; Lee CG; Park YS; Kim SD; Yoon SO; Han DH; Lee KY; Jeong MH; Jo WS
    Immunobiology; 2017 Jan; 222(1):55-65. PubMed ID: 26705936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage polarization in the tumor microenvironment: Emerging roles and therapeutic potentials.
    Zhang W; Wang M; Ji C; Liu X; Gu B; Dong T
    Biomed Pharmacother; 2024 Aug; 177():116930. PubMed ID: 38878638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low doses of gamma irradiation potentially modifies immunosuppressive tumor microenvironment by retuning tumor-associated macrophages: lesson from insulinoma.
    Prakash H; Klug F; Nadella V; Mazumdar V; Schmitz-Winnenthal H; Umansky L
    Carcinogenesis; 2016 Mar; 37(3):301-313. PubMed ID: 26785731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. M1 Macrophage-Derived Nanovesicles Potentiate the Anticancer Efficacy of Immune Checkpoint Inhibitors.
    Choo YW; Kang M; Kim HY; Han J; Kang S; Lee JR; Jeong GJ; Kwon SP; Song SY; Go S; Jung M; Hong J; Kim BS
    ACS Nano; 2018 Sep; 12(9):8977-8993. PubMed ID: 30133260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Redirecting tumor-associated macrophages to become tumoricidal effectors as a novel strategy for cancer therapy.
    Zheng X; Turkowski K; Mora J; Brüne B; Seeger W; Weigert A; Savai R
    Oncotarget; 2017 Jul; 8(29):48436-48452. PubMed ID: 28467800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ontogeny of Tumor-Associated Macrophages.
    Laviron M; Boissonnas A
    Front Immunol; 2019; 10():1799. PubMed ID: 31417566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological Effects of Nanoparticles on Macrophage Polarization in the Tumor Microenvironment.
    Reichel D; Tripathi M; Perez JM
    Nanotheranostics; 2019; 3(1):66-88. PubMed ID: 30662824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor associated macrophages and neutrophils in tumor progression.
    Galdiero MR; Garlanda C; Jaillon S; Marone G; Mantovani A
    J Cell Physiol; 2013 Jul; 228(7):1404-12. PubMed ID: 23065796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunology in the clinic review series; focus on cancer: tumour-associated macrophages: undisputed stars of the inflammatory tumour microenvironment.
    Allavena P; Mantovani A
    Clin Exp Immunol; 2012 Feb; 167(2):195-205. PubMed ID: 22235995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential applications of macrophages in cancer immunotherapy.
    Sadri M; Heidari S; Faridzadeh A; Roozbehani M; Toosi S; Mahmoudian RA; Hoseinzadeh A; Salmani Fard MT; Arab FL; Fard SR; Faraji F
    Biomed Pharmacother; 2024 Sep; 178():117161. PubMed ID: 39047419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re-education of macrophages as a therapeutic strategy in cancer.
    Kowal J; Kornete M; Joyce JA
    Immunotherapy; 2019 Jun; 11(8):677-689. PubMed ID: 31088236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-derived extracellular vesicles activate primary monocytes.
    Gärtner K; Battke C; Dünzkofer J; Hüls C; von Neubeck B; Kellner MK; Fiestas E; Fackler S; Lang S; Zeidler R
    Cancer Med; 2018 May; 7(5):2013-2020. PubMed ID: 29601673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of tumor-associated macrophages in human malignancies: friend or foe?
    Takeya M; Komohara Y
    Pathol Int; 2016 Sep; 66(9):491-505. PubMed ID: 27444136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor promoting role of anti-tumor macrophages in tumor microenvironment.
    Goswami KK; Ghosh T; Ghosh S; Sarkar M; Bose A; Baral R
    Cell Immunol; 2017 Jun; 316():1-10. PubMed ID: 28433198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of phagocytosis by immune checkpoint blockade.
    Li CW; Lai YJ; Hsu JL; Hung MC
    Front Med; 2018 Aug; 12(4):473-480. PubMed ID: 30062558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress in tumor-associated macrophage (TAM)-targeted therapeutics.
    Ngambenjawong C; Gustafson HH; Pun SH
    Adv Drug Deliv Rev; 2017 May; 114():206-221. PubMed ID: 28449873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of CXC Chemokine Receptors 1-4 on Immune Cells in the Tumor Microenvironment.
    Susek KH; Karvouni M; Alici E; Lundqvist A
    Front Immunol; 2018; 9():2159. PubMed ID: 30319622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.